Page 3 - Johan Skog News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johan skog. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johan Skog Today - Breaking & Trending Today

Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases

/PRNewswire/ Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has published important clinical research in. ....

United States , Erik Margolis , Johan Skog , Chuck Kummeth , David Clair , Investor Relations Corporate Development , National Comprehensive Cancer Network , Bio Techne Corporation , United States Preventive Task Force , Exosome Diagnostics , Prostate Cancer , Prostatic Diseases , Prostate Intelliscore , Englewood Hospital , Medical Center , Exodx Prostate , Active Surveillance , Chief Scientific Officer , Chief Executive , Senior Director , Investor Relations , Health Care Amp Hospitals , Biotechnology , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,

Bio-Techne Announces Paper Publication In Annals Of Oncology

Share this article
Share this article
MINNEAPOLIS, Feb. 11, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has recently published a paper entitled
Exosome-based Liquid Biopsies in Cancer: Opportunities and Challenges (Yu, W et al.), in the highly rated peer-reviewed journal,
Annals of Oncology (link). This review paper provides unique insight into liquid biopsies and the field of exosomes in the context of other liquid biopsies such as cfDNA and CTC analysis. The exosome field has gone through a rapid growth phase in parallel with the increasing attention over the potential of liquid biopsies. Despite recent progress of liquid biopsies for late-stage cancers, there remains a need to improve both the accuracy and utility of these tests, especially in earlier stage cancers. This will likely require a combination of approaches that exploit biomarkers released through different processes. Exosom ....

Johan Skog , Chuck Kummeth , David Clair , Investor Relations Corporate Development , Bio Techne Corporation , Exosome Diagnostics , Liquid Biopsies , Exosome Diagnostics Chief Scientific Officer , Exodx Prostate , Chief Executive Officer , Senior Director , Investor Relations , டேவிட் கிளேர் , முதலீட்டாளர் உறவுகள் பெருநிறுவன வளர்ச்சி , உயிர் தொழில்நுட்பம் நிறுவனம் , தலைமை நிர்வாகி அதிகாரி , மூத்தவர் இயக்குனர் , முதலீட்டாளர் உறவுகள் ,